Ali­gos co-founders shoot back at J&J IP com­plaint with one of their own al­leg­ing fraud

This sto­ry goes all the way back to 2014.

In No­vem­ber of 2014, John­son & John­son ac­quired Alios Bio­Phar­ma, an in­fec­tious dis­ease biotech that was co-found­ed by Lawrence Blatt and Leonid Beigel­man.

Fol­low­ing J&J’s 2014 ac­qui­si­tion, Blatt and Beigel­man would be­come em­ploy­ees at J&J’s Janssen arm, with Blatt be­ing the glob­al head of in­fec­tious dis­eases and vac­cines and Beigel­man be­ing Janssen’s VP of med­i­c­i­nal chem­istry. But Blatt and Beigel­man left Janssen in 2017, start­ing Ali­gos one year lat­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER